CHRISTUS Santa Rosa Hospital in New Braunfels is making a significant impact on heart health in the community with its Transcatheter Aortic Valve Replacement program.

J&J inherited the Javelin catheter as part of its $13.1bn acquisition of Shockwave Medical, which completed in June 2024.

The mean age for men with occluded or narrowed arteries, or both, was 50 years and for women 59 years. Most of the stenotic changes were seen at the orifices or in the first part of the arteries. The ...

NASS’s 2024 Research Funding Program announced grants and traveling fellowships winners totaling $159,059 this year.

One of the longstanding challenges of pediatric pulmonary valve replacement is size and the ability to accommodate growth.

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

Cardiawave said its device for the treatment of severe symptomatic calcific aortic stenosis (CAS) met the primary endpoint in ...

The expected outcome is successful treatment of the stenotic vessel; however, treatment may not totally correct the problem. Careful monitoring of blood pressure for hypertension becomes a long ...

WASHINGTON--Cardiawave SA, developer of the groundbreaking Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for the ...

Symptomatic improvement has been well demonstrated in a number of studies and is usually sustained into the late postoperative period, especially when valve replacement is undertaken for stenotic ...

Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.